Skip to main content
Medinice S.A. logo

Medinice S.A. — Investor Relations & Filings

Ticker · ICE ISIN · PLMDNCE00016 LEI · 259400LGO9UDV1Y18Z11 WAR Manufacturing
Open in API
Filings indexed 761 across all filing types
Latest filing 2023-03-28 Regulatory Filings
Country PL Poland
Listing WAR ICE

About Medinice S.A.

https://www.medinice.pl/?lang=2

Medinice S.A. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions in the fields of cardiology and cardiac surgery. The company's mission is to create patient-focused technologies that improve the quality of life for individuals with cardiac diseases. Its portfolio consists of advanced medical devices, including Class III devices, which undergo a full research, development, and clinical trial process before market introduction. Key projects include CoolCryo, a cryoablation system; AtriClamp, for left atrial appendage closure; and PacePress, a specialized compression band used after cardiac device implantation procedures.

Recent filings

Filing Released Lang Actions
Otrzymanie ochrony patentowej od Kanadyjskiego Urządu Patentowego na wynalazek "PNEUMATYCZNY BANDAŻ UCISKOWY". - Content (EN)
Regulatory Filings Classification · 95% confidence The document text is very short (664 characters) and announces the receipt of confirmation of patent protection from the Canadian Patent Office for an invention related to a 'pneumatic compression bandage' (Project 'PacePress'). This is a specific announcement regarding intellectual property or a key operational development, but it does not fit the definitions for standard financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (DIV, DVA). Since it is a specific, non-standard announcement that doesn't fit the primary categories, the most appropriate fallback is the general Regulatory Filings category (RNS), as it represents an official, material announcement that is not otherwise classified.
2023-03-28 English
Otrzymanie ochrony patentowej od Kanadyjskiego Urządu Patentowego na wynalazek "PNEUMATYCZNY BANDAŻ UCISKOWY". - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is very short (581 characters) and announces that the Management Board of Medinice S.A. received confirmation of patent protection from the Canadian Patent Office for an invention titled "pneumatic compression bandage" (PacePress project). This is a specific announcement regarding intellectual property protection, which does not fit neatly into the primary financial reporting categories (10-K, IR, ER, etc.). Since it is a specific regulatory/legal update concerning intellectual property, it is best classified as a general Regulatory Filing (RNS) as it is not a Legal Proceedings Report (LTR) which usually implies litigation, nor is it a financing or share transaction announcement. Given the options, RNS serves as the most appropriate general regulatory announcement category for patent confirmation.
2023-03-28 Polish
Zawarcie umowy z doradcą transakcyjnym Clairfield Partners LLC - Content (EN)
M&A Activity Classification · 95% confidence The document describes the engagement of an advisor (Clairfield Partners LLC) to assist Medinice S.A. with the commercialization process of its medical devices, including due diligence and negotiation strategy. This involves a significant corporate transaction or strategic partnership that impacts the company's operations and financial position. This type of announcement, detailing a strategic agreement or advisory role for a major corporate activity (like potential M&A or commercialization strategy), fits best under the category of M&A Activity (TAR) or potentially a general Regulatory Filing (RNS) if it doesn't strictly meet the M&A definition. Since the advisory role is explicitly tied to the 'commercialisation process' and involves due diligence and negotiation strategy for key projects, it strongly suggests preparatory work for a major transaction, which aligns closely with M&A Activity (TAR). Given the context of advising on commercialization and due diligence, TAR is the most specific fit, although it is not a formal takeover bid announcement.
2023-03-20 English
Zawarcie umowy z doradcą transakcyjnym Clairfield Partners LLC - Content (PL)
M&A Activity Classification · 95% confidence The document text, written in Polish, describes Medinice S.A. entering into an agreement with Clairfield Partners LLC for advisory services related to the commercialization of medical devices. This involves due diligence, negotiation strategy, and coordination for key projects (Pacepress, CoolCryo, etc.). The agreement includes fixed and success fees. The management deems this information material because it will significantly impact the company's operations and financial situation. This clearly describes an activity related to mergers, acquisitions, or significant strategic transactions/partnerships aimed at commercializing assets, which aligns best with the M&A Activity category (TAR). It is not a standard financial report (10-K, IR, ER) or a management change announcement (MANG).
2023-03-20 Polish
Otrzymanie ochrony patentowej od Południowokoreańskiego Urządu Patentowego na wynalazek "PNEUMATYCZNY BANDAŻ UCISKOWY". - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is very short (726 characters) and announces that the Management Board of Medinice S.A. received patent protection confirmation from the South Korean Patent Office for an invention titled "pneumatic compression bandage." This is a specific announcement regarding intellectual property or a regulatory/legal milestone, but it is not a full financial report (like 10-K or IR) or a standard earnings release (ER). It details a specific legal/IP event. Given the options, this type of announcement about obtaining a patent or regulatory approval fits best under the general 'Regulatory Filings' (RNS) category, as it is a specific, non-financial regulatory update that doesn't align with DIRS, DIV, or M&A. It is not a Legal Proceedings Report (LTR) as it is positive news about obtaining protection, not reporting on a lawsuit. Therefore, RNS is the most appropriate fallback for this specific regulatory/IP update.
2023-03-16 Polish
Zawiadomienie o zmianie stanu posiadania udziału w ogólnej liczbie głosów w spółce - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document text is in Polish and discusses a notification received by Medinice S.A. from a shareholder, Esaliens TFI S.A., regarding a change in their shareholding percentage. The notification is made pursuant to Article 69 and Article 87 of the Polish Public Offering Act, stating that the shareholder's stake has fallen below the 5% threshold following a sale of shares on February 10, 2023. This type of filing, reporting a change in significant share ownership that crosses a regulatory threshold (like 5%), directly corresponds to the definition of Major Shareholding Notification (MRQ). The document length is very short (726 chars), but it is the primary notification itself, not an announcement of a report, thus MRQ is the most appropriate classification.
2023-02-14 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.